Skip to content

Datenblatt ansehen

open_in_new
  1. Alles ansehen
  2. Monoclonal

200-301-P49

VEGFR2 Antibody

Eine Lieferung in diese Region ist nicht möglich.

SKU:
200-301-P49
Zusätzliche Namen:
CD309, VEGFR, FLK1, VEGFR2, TYROSINE KINASE GROWTH FACTOR RECEPTOR, FLK1, MOUSE, HOMOLOG OF, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2, Fetal liver kinase 1, Kinase insert domain receptor, Protein-tyrosine kinase receptor flk-1|KDR
Anwendung:
IHC
Konzentration:
1 mg/ml
Physischer Zustand:
Lyophilized
Spezies-Reaktivität:
Human
Lagerbedingungen:
Please refer to datasheet
Hersteller:
Rockland Inc
Host:
Mouse
Reaktivitäten:
Human
Buffer:
1.2% sodium acetate
Immunogen:
VEGFR2 antibody was produced in mice by repeated immunizations with recombinant protein corresponding to human extracellular domain of VEGFR-2 (KDR).
Formulierung:
1.2% sodium acetate
Klon:
KDR-1
Uniprot:
P35968
Synonyme:
CD309;Fetal liver kinase 1;fetal liver kinase-1;FLK1;Kinase insert domain receptor;kinase insert domain receptor (a type III receptor tyrosine kinase);protein-tyrosine kinase receptor Flk-1;soluble VEGFR2;tyrosine kinase growth factor receptor;vascular endothelial growth factor receptor 2;VEGFR;VEGFR2
Weitere Details:
VEGF, a homodimeric glycoprotein of relative molecular mass 45,000, is the only mitogen that specifically acts on endothelial cells. The importance of VEGF and its receptor system in tumor growth and intervention in this system may provide promising approaches to cancer therapy. VEGF receptor 2 is a member of a receptor tyrosine kinase family.Like other growth factor receptors, upon ligand binding VEGF receptor 2 dimerises and is autophosphorylated on multiple tyrosine residues. This antibody is suitable for researchers interested in cell signaling and cancer research.
Versandbedingungen:
Ambient